09/26/2024 | Press release | Distributed by Public on 09/26/2024 14:46
Item 5.07 Submission of Matters to a Vote of Security Holders.
On September 26, 2024, Altimmune, Inc. (the "Company") held its 2024 Annual Meeting of Stockholders (the "2024 Annual Meeting"). As of August 12, 2024, the record date for the 2024 Annual Meeting, there were 71,070,951 shares of the Company's common stock outstanding and entitled to vote at the 2024 Annual Meeting. A total of 43,676,304 shares of common stock were present or represented by proxy at the 2024 Annual Meeting, representing 61.5% of the issued and outstanding shares entitled to vote at the meeting, representing a quorum. The proposals voted upon and the final results of the vote were as follows:
Proposal No. 1: Election of Directors. The results were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
Broker |
|
Director |
|
For |
|
Withhold |
|
Non-Votes |
Mitchel Sayare, Ph.D., Chairman |
|
21,231,279 |
660,730 |
21,784,295 |
||
Vipin K. Garg, Ph.D. |
|
21,248,551 |
643,458 |
21,784,295 |
||
John M. Gill |
|
21,124,044 |
767,965 |
21,784,295 |
||
Philip L. Hodges |
|
17,824,841 |
4,067,168 |
21,784,295 |
||
Diane Jorkasky, M.D. |
|
21,264,188 |
627,821 |
21,784,295 |
||
Wayne Pisano |
|
15,375,257 |
6,516,752 |
21,784,295 |
||
Klaus O. Schafer, M.D., MPH |
21,246,089 |
645,920 |
21,784,295 |
|||
Catherine Sohn, Pharm D |
20,914,390 |
977,619 |
21,784,295 |
Proposal No. 2: Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024. The results were as follows:
|
|
|
|
|
For |
|
Against |
|
Abstain |
43,204,496 |
|
315,411 |
156,397 |
Proposal No. 3: Advisory vote on the Compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the SEC's compensation rules (referred to as the "say-on-pay" proposal). The results were as follows:
|
|
|
|
|
|
|
For |
|
Against |
|
Abstain |
|
Broker Non-Votes |
13,663,909 |
|
7,992,177 |
|
235,923 |
21,784,295 |
Proposal No. 4: Vote to authorize the adjournment of the 2024 Annual Meeting to enable the Board of Directors to solicit additional proxies. The results were as follows:
|
|
|
|
|
For |
|
Against |
|
Abstain |
26,771,350 |
|
16,249,120 |
655,834 |